tumour pathology Flashcards

1
Q

what is a neoplasm

A

A neoplasm is an abnormal mass of tissue , the growth of which exceeds and is uncoordinated with that of the normal tissues and persists in same excessive manner after cessation of the stimuli which evoked change.

Abnormal mass is purposeless, preys on the host and virtually autonomous.

Two fundamental features of neoplasm are unregulated growth and clonal genetic defects (derived from single cell and all the cells in the neoplasm are clonal related)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

metastasis

A

spread to distant, non-contiguous site
Lymphatic metastasis (spread to lymph nodes)
Haematogenous metastasis (spread to lung, liver, bone, brain, etc)
Implantation in body cavities (Pleural and peritoneal metastasis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

benign neoplasms

A

Cohesive, expansile, well demarcated masses, do not invade or infiltrate surrounding normal tissue (can push local structures, put pressure on them but do not invade)
Usually progressive and slow growth (can be seen on clinical and radiological examination); may come to a standstill or regress; mitotic figures rare and normal - some benign tumours have higher growth rates than malignant tumours
Well differentiated; structure sometimes typical of tissue of origin
Do not metastasize

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

malignant neoplasms

A

Locally invasive, infiltrating surrounding tissue; sometimes may be misleadingly cohesive and expansile
Infiltrative borders - stellate, spiculated (Can be seen on radiological and histopathological examination).
Locally advanced malignant tumours are fixed to adjacent structures and not mobile. (Clinical examination – palpation of the tumour)
May grow slowly or rapidly; mitotic figures may be numerous and abnormal
Some lack of differentiation (anaplasia); structure often atypical
Metastasis - Frequent; more likely with large undifferentiated primary tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

anaplasia

A

anaplasia- lack of differentiation
Abnormal nuclei - high nucleus to cytoplasmic ratio, hyperchromatic nuclei (due to replicating DNA), clumped chromatin, prominent nucleoli
Anaplastic nuclei may have multiple copies of chromosomes and therefore more DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

pleomorphism

A

variation in size and shape of cells and nuclei, abnormal mitotic figures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

benign epithelial neoplasms

A

Adenoma - derived from glandular epithelium
Cystadenoma - benign epithelial neoplasm with cystic or fluid filled cavity
Papilloma - benign epithelial neoplasm producing finger like projections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

benign mesenchymal neoplasms

A
Fat – Lipoma
Smooth muscle – Leiomyoma
Skeletal muscle – Rhabdomyoma
Cartilage – Chondroma
Bone – Osteoma
Blood vessels – Haemangioma
Fibrous tissue - Fibroma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

malignant neoplasms (nomenclature)

A

Carcinoma - arising from epithelial tissue
Adenocarcinoma - arising from glandular epithelium
Squamous cell carcinoma – arising from squamous epithelium
Small cell carcinoma – arising from neuroendocrine cells or pleuripotent stem cells
Melanoma – arising from melanocytes
Sarcoma - arising from mesenchymal tissue
Lymphoma - arising from lymphoid tissue
Leukaemia - arising from blood or bone marrow elements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

definitions: mixed tumours, teratomas, blastomas

A
  • Neoplasms with more than one cell type but arising from only one germ layer are called ‘mixed tumours’
  • Neoplasms with more than one cell type and arising from more than one germ layer are called teratomas
  • Neoplasms ending in ‘blastoma’ resemble primitive embryonic tissues, which are often paediatric neoplasms (e.g. Retinoblastoma, Neuroblastoma)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is tumour grade?

A

Histologic parameter quantifying degree of differentiation

Well differentiated (low grade) tumours resemble mature normal cells of the tissue of origin

Poorly differentiated (high grade) tumours show little resemblance to tissue of origin

Limitations - Many tumours show intermediate differentiation, sampling error in small biopsies, interobserver variation for assessment of grade (subjective light microscopic interpretation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is tumour stage?

A

AJCC and UICC (TNM)

Size of the tumour, extent of invasion, lymph node involvement, distant metastasis

Important in planning appropriate treatment, prognosis, research and guidelines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the clinical manifestations of cancer?

A
Cancer can cause illness by
Local invasion and impingement on local structures
Ulceration, bleeding and infection
Cachexia
Paraneoplastic process
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

causes of neoplasia

A

Environmental causes – Chemicals, Oncogenic viruses, Radiation

Hereditary causes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

carcinogen

A

An external agent that increases the incidence of malignant neoplasms, reduces their latency, or increases their severity or multiplicity – WHO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

chemical carcinogens

A
  • There are two steps: initiation and promotion
  • An initiating carcinogenic agent irreversibly damages cell DNA (it is mutagenic) to start the process
  • A promoting agent (which may be the same as the carcinogen) then acts (reversibly) to cause proliferation of a neoplastic cell clone, but there appears to be a “dose-threshold” concentration of promoter below which neoplasia will not occur.
Many chemical carcinogens are highly reactive electrophiles (have electron deficient atoms) that can react with nucleophilic (electron rich) sites in the cell, including DNA, RNA and protein.
Direct carcinogens (direct acting alkylating agents)
Indirect carcinogens (aka procarcinogens) - Metabolite is the active carcinogen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

types of procarcinogens

A

Polycyclic aromatic hydrocarbons: the most potent carcinogen, produced in combustion of tobacco, can cause lung and bladder cancers
Tobacco smoke contains over 4000 chemical compounds
Aromatic amines (in dye and rubber) and azo dye (food colour)
Naturally occurring carcinogens: aflatoxin B in stored peanuts and grains, cause liver cancer
Nitrosamines and amides: nitrate preservatives are converted by bacteria in gastrointestinal tract and may contribute to gastric cancer

18
Q

metabolic activation of procarcinogens

A

Most known carcinogens are metabolized and activated by cytochrome P-450 dependent mono- oxygenases
A P-450 gene product, CYP1A1 metabolize polycyclic aromatic hydrocarbons
Cytochrome P-450 enzymes are polymorphic
A highly inducible form of CYP1A1 is associated with higher risk to develop lung cancer in smokers.

Inactivation of procarcinogen or its derivatives
Glutathione-S-transferase (GST) inactivates polycyclic aromatic hydrocarbons
GST is deleted in many patients, who incur a higher risk of lung and bladder cancer if exposed to tobacco smoke.

19
Q

occupational cancer

A
Examples of occupational cancers 
Arsenic (metal smelting, herbicide)
lung and skin cancers
Asbestos (fire-resistant textile, brake lining, tiles)
lung, mesothelioma and GI tract cancers
Benzene (light oil, paint, dry cleaning)
leukaemia, Hodgkin lymphoma
Vinyl chloride (refrigerant and plastics)
Angiosarcoma and liver cancer
20
Q

radiation

A

• Ultraviolet light
Skin cancers

• Ionizing radiation (X-rays, gamma rays)
Leukaemia, thyroid, breast and many others

21
Q

infectious agent carcinoma

A

Viruses:
Human papilloma virus (HPV) – Cervical cancer
Epstein-Barr Virus (EBV) – Lymphoma, Nasopharyngeal carcinoma
Hepatitis B and C viruses – Liver Cancer
Human T-cell lymphotrophic virus-1– Leukaemia/lymphoma
Bacteria:
Helicobacter Pylori – Stomach Cancer (Lymphoma and carcinoma)
Parasites:
Shcistosoma haematobium–Bladder Cancer
Opisthorchis viverrini– Bile duct cancer

22
Q

dietary carcinogens

A

Aflatoxins (product of mould on peanuts, etc)
Liver cancer
Arsenic
Lung and skin cancer

23
Q

therapeutic carcinogens

A
  • Many chemotherapy agents (lymphomas and leukemias).

* Estrogenic hormones (endometrium, breast).

24
Q

cultural and lifestyle habits

A

Tobacco smoke – Lung and respiratory tract, kidney, bladder, and pancreas cancers
Ethanol – Liver, upper aerodigestive tract cancers
Betel quid – Mouth cancer
Smokeless tobacco – Mouth cancer

Obesity - Colon, endometrial, breast cancer

25
Q

inherited cancer syndromes - autosomal dominant

A

Autosomal Dominant
Inheritance of a mutated allele of a single tumour suppressor gene increases the risk of cancer

Retinoblastoma: Rb
Li-Fraumeni syndrome: p53
Neurofibromatosis 1 and 2: NF1, NF2
Melanoma: p16INK4A
Breast and Ovarian: BRCA1,BRCA2
Multiple endocrine neoplasia 1 and 2: MEN1, RET
Basal cell carcinoma: PATCH
Familial adenomatous polyposis (FAP): APC
26
Q

inherited cancer syndromes- autosomal recessive

A
Mostly defects in DNA repair
• Xeroderma Pigmentosum
• Ataxia-telangiectasia
• Bloom Syndrome
• Fanconi Anaemia
27
Q

unclassified familial clusters

A

Virtually all common cancers have familial forms that are not well defined
Cancers in multiple close relatives
Multiple cancers in individuals
Persistence over several generations
Most have unclear (?multigene?) inheritance patterns
Many more genetic causes of familial cancer remain to be discovered!
High rate of cancer within family, but unclear mechanism of inheritance, and no genetic defect identified

28
Q

defective DNA repair syndromes

A

Defect in DNA repair and resultant DNA instability

e.g. Lynch syndrome, Xeroderma pigmentosum

29
Q

cellular transformation

A

There are “pre-cancerous” conditions in which malignant neoplasia is more likely to occur (but not in every case): liver cirrhosis, chronic ulcerative colitis, atrophic gastritis, epidermal actinic keratosis, and oral leukoplakia. In these cases, there is ongoing cellular proliferation for repair of damaged tissue, often from ongoing inflammation. Abnormal cell proliferation leads to a greater likelihood for mutation to occur.

30
Q

hyperplasia

A

An increase in the number of cells in an organ or tissue, which may then have increased volume.

Physiologic hyperplasia – e.g. Postpartum breast lobules undergo hyperplasia for lactation

Pathologic hyperplasia – e.g. Endometrial hyperplasia in a postmenopausal woman – Fertile soil in which cancerous proliferation may arise

31
Q

metaplasia

A

Metaplasia is a reversible change in which one adult cell type is replaced by another adult cell type

e.g. Columnar to squamous in respiratory tract due to chronic irritation
Squamous to columnar in Barrett’s oesophagus

32
Q

dysplasia

A

An increasing degree of disordered growth or maturation of the tissue (often thought to precede neoplasia) such as cervical dysplasia as a result of human papillomavirus infection. Dysplasia is still a reversible process. However, once the transformation to neoplasia has been made, the process is not reversible.

33
Q

characteristics of cancer

A
  • sustaining proliferative signalling
  • avoiding immune destruction
  • evading immune suppressors
  • enabling replicative immortality
  • tumour-promoting inflammation
  • activation invasion and metastasis
  • genomic instability (mutator phenotype)
  • inducing angiogenesis
  • resisting cell death
  • deregulating cellular energetics
34
Q

activation of Non- Receptor Kinases

A

1) BCR-ABL translocation in Chronic myeloid leukaemia
- bcr-abl fusion protein has sustained tyrosine kinase activity
- derives CML: oncogene addiction
- Gleevac inhibits TK activity

2) JAK-2 Mutations
- sustained activation of the STAT signalling pathway
- occurs in chronic myoproliferative disorders
- > Polycythemia vera
- > primary myelofibrosis

35
Q

mutational activation of nuclear transcription factors

A
  • drive the cell cycle in the absence of any growth promoting signals
  • MYC most commonly involved
  • mutant MYC upregulates Cyclin-depent kinases CDKs and inhibits their inhibitors (CDKIs)
  • mutant MYC promotes aerobic glycosylation (Warburg effect)
36
Q

Rb gene

A

RB is a tumour suppressor gene, it monitors G1-s checkpoint.

hypophosphorylated Rb sequester E2F and prevents transcription of genes required for DNA synthesis such as cyclin E

37
Q

tumour suppressor gene

A

prevents cell growth/division

loss of function

car brakes

two hits

38
Q

proto-oncogenes/oncogenes

A

promotes cell growth/division

gain of function
car accelerator

one hit

39
Q

enabling replicative immortality

A
  • tumour cells use an enzyme called telomerase which adds telomeres onto the end of chromosomes
  • cell can now divide indefinitely without entering senescence
40
Q

tumour promoting inflammation

A
  • many tumours are infiltrated with leukocytes of all types
  • these may be manifestations of host responses to tumours
  • it seems that inflammatory cells may promote tumour growth
  • > secretion of EGF and VEGF
  • > secretion of MMPs that digest the stroma and create planes for invasion
  • > release free radicals- additional DNA damage
41
Q

deregulating cellular energetics

A
  • ’ aerobic glycolysis’
  • tumour cells convert glucose -> lactate in the presence of oxygen
  • less efficient than normal glycolysis
  • increased expression of GLUT1 as compensation
  • facilitates the biosynthesis of macromolecules (amino acid precursors) for formation of daughter cells